About three weeks ago, the Index Department published a provisional list of newly valid outstanding share totals and….
free float values.
In the meantime, some last-minute changes have been taken into account in order to ensure that the new index basket weights correspond to the current status.
For the SLI® as well as for the SXI Life Sciences® and SXI Bio+Medtech®, large-capitalisation issues are again capped at 9% and 4.5% (SLI®) and at 10% (SXI®) on the basis of the closing prices of 12 March 2010.
Source: ETFWorld – SIX Swiss Exchange
Subscribe to Our Newsletter
